Key facts
- This page summarizes Xiao-Hui Chen's Form 3 filing for BELITE BIO, INC (BLTE).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 14:36.
Xiao-Hui Chen - 18 Mar 2026 Form 3 Insider Report for BELITE BIO, INC (BLTE)
- Reporting relationship
- Director
- Issuer ticker
- BLTE
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Xiao-Hui Chen
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Xiao-Hui Chen filed Form 3 for BELITE BIO, INC (BLTE) on 18 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002106182
Primary reporting owner
Chen Xiao-Hui
- Relationship
- Director
- Address
- 36F, NO.68, SEC.5, ZHONGXIAO E. RD., XINYI DIST, TAIPEI CITY, TAIWAN
- Signature
- /s/ Xiao-Hui Chen
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
BLTE
holding
American depositary share
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 400
- Date
- 18 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Each American depositary share represents one ordinary share, par value US$0.0001 per share, of the Issuer.
SEC remarks
Exhibit 24 - Power of Attorney